RPS6KB1 and breast cancer: We also found that in cells expressing cancer-associated hyperactivating MTOR mutations, the growth inhibitory effects of BC-LI-0186, rapamycin, and INK128 were comparable to the inhibitory effects on S6K phosphorylation (Supplementary Table 2).